KUALA LUMPUR: Optimax Holdings Bhd, an eye specialist service provider, recorded revenue of RM37.4 million for Q2 ended Dec 31, 2026 (FY27), marking a 9.6% year-on-year (YoY) growth.
The increase was mainly driven by its effective online marketing initiatives and stronger contributions from the group’s operations in East Malaysia and Cambodia, which recorded revenue growth of 20.4% and 404.3% respectively.
The record quarterly revenue led to profit before tax (PBT) and profit after tax (PAT) of RM5.9 million and RM4.5 million, respectively.
For the cumulative 6 months (1H) of FY26, Optimax recorded RM68.0 million in revenue, representing a 5.5% YoY increase from RM64.4 million in 1H FY25.
The group’s PBT was RM10.0 million while PAT was RM7.5 million.
Optimax CEO Sandy Tan said effective digital marketing initiatives supported the earnings performance, and benefits from its expansion initiatives are also beginning to translate into tangible results.
“In particular, our Cambodia operations continued to gain strong momentum, with revenue increasing fivefold, reflecting growing patient demand and encouraging traction in the market.
“Looking ahead, we will continue to strengthen our presence in East Malaysia and Cambodia. Another milestone was the recent launch of our first ENT clinic at Atria Mall in August 2026.
“This new service allows us to leverage our existing operating theatre facilities and infrastructure, which we expect will further improve utilisation while creating an additional revenue stream.
“We will continue to explore complementary healthcare services that allow us to better serve our patients and capture opportunities arising from the evolving healthcare landscape,” she said.
